AP125RX Inactivated Actinobacillus pleuropneumoniae (Total bacterial count) 41-1 strain (serotype 1) (seed), SHP-1 strain 9serotype 2) (seed), Ng-2 strain (serotype 5) (seed)- 1.0x10^9 ~5.0x10^9 cells each; Non-toxigenic cytotoxic cytotoxins of Actinobacillus pleuropneumoniae (derived from recombinant Escherichia coli) rApx I Protein (seed), rApx II protein (seed), rApx III Protein (seed) - 80-120 mcg each Suspension for Injection (IN Philippines - English - FDA (Food And Drug Administration)

ap125rx inactivated actinobacillus pleuropneumoniae (total bacterial count) 41-1 strain (serotype 1) (seed), shp-1 strain 9serotype 2) (seed), ng-2 strain (serotype 5) (seed)- 1.0x10^9 ~5.0x10^9 cells each; non-toxigenic cytotoxic cytotoxins of actinobacillus pleuropneumoniae (derived from recombinant escherichia coli) rapx i protein (seed), rapx ii protein (seed), rapx iii protein (seed) - 80-120 mcg each suspension for injection (in

superiorvet inc.; distributor: superiorvet inc. - inactivated actinobacillus pleuropneumoniae vaccine (vet.) - suspension for injection (in - inactivated actinobacillus pleuropneumoniae (total bacterial count) 41-1 strain (serotype 1) (seed), shp-1 strain 9serotype 2) (seed), ng-2 strain (serotype 5) (seed)- 1.0x10^9 ~5.0x10^9 cells each; non-toxigenic cytotoxic cytotoxins of actinobacillus pleuropneumoniae (derived from recombinant escherichia coli) rapx i protein (seed), rapx ii protein (seed), rapx iii protein (seed) - 80-120 mcg each

APM777 Formulation: Each 2 mL (dose) contains: Actinobacillus pleuropneumoniae, Serotype 1 (41-1 Strain) ............... 1-5 x 109 Cells Serotype 2 (SHP-1 Strain) ............... 1-5 x 10° Cells Serotype 5 (Ng-2 Strain) ............... 1-5 x 10° Cells Actinobacillus pleuropneumoniae Cytotoxin rApx I, II, III Protein ....... 80-120 ug (Recombinant A. pleuropneumoniae produced in Escherichia coli) Mesomycoplasma hyopneumoniae (MI-3 Strain) .......... ........ 21 x 108 Cells Vaccine Philippines - English - FDA (Food And Drug Administration)

apm777 formulation: each 2 ml (dose) contains: actinobacillus pleuropneumoniae, serotype 1 (41-1 strain) ............... 1-5 x 109 cells serotype 2 (shp-1 strain) ............... 1-5 x 10° cells serotype 5 (ng-2 strain) ............... 1-5 x 10° cells actinobacillus pleuropneumoniae cytotoxin rapx i, ii, iii protein ....... 80-120 ug (recombinant a. pleuropneumoniae produced in escherichia coli) mesomycoplasma hyopneumoniae (mi-3 strain) .......... ........ 21 x 108 cells vaccine

superiorvet inc.; distributor: superiorvet inc. - inactivated actinobacillus pleuropneumoniae , mesomycoplasma hyopneumoniae vaccine (vet.) - vaccine - formulation: each 2 ml (dose) contains: actinobacillus pleuropneumoniae, serotype 1 (41-1 strain) ............... 1-5 x 109 cells serotype 2 (shp-1 strain) ............... 1-5 x 10° cells serotype 5 (ng-2 strain) ............... 1-5 x 10° cells actinobacillus pleuropneumoniae cytotoxin rapx i, ii, iii protein ....... 80-120 ug (recombinant a. pleuropneumoniae produced in escherichia coli) mesomycoplasma hyopneumoniae (mi-3 strain) .......... ........ 21 x 108 cells

Porcilis App Each dose (2 mL) contains: Actinobacillus pleuropneumoniae antigen concentrate...................600 mg Antigen concentrate contains: Outer Membrane Protein (OMP) antigen (Appl-L-452 strain)..............50 units Apxl antigen (App HV169 strain) ..................50 units ApxII antigen (App HV143 strain) ..................50 units ApxII + ApxIII antigen (App 2 strain) .................50 units Antigens incorporated in aqueous adjuvant contains: dl-a-Tocopherol acetate................150 mg Polysorbate 80..................60 mg Simethicone ...............100 mcg Sodium chloride ..................11 mg Formalin ................1.08 mg Water ......2 mL 150 mg 60 mg 100 mcg 11 mg ... 1.08 mg ........ 2 mL Suspension for Injection (IM) Philippines - English - FDA (Food And Drug Administration)

porcilis app each dose (2 ml) contains: actinobacillus pleuropneumoniae antigen concentrate...................600 mg antigen concentrate contains: outer membrane protein (omp) antigen (appl-l-452 strain)..............50 units apxl antigen (app hv169 strain) ..................50 units apxii antigen (app hv143 strain) ..................50 units apxii + apxiii antigen (app 2 strain) .................50 units antigens incorporated in aqueous adjuvant contains: dl-a-tocopherol acetate................150 mg polysorbate 80..................60 mg simethicone ...............100 mcg sodium chloride ..................11 mg formalin ................1.08 mg water ......2 ml 150 mg 60 mg 100 mcg 11 mg ... 1.08 mg ........ 2 ml suspension for injection (im)

msd animal health (phils.), inc.; distributor: msd animal health (phils.), inc. - inactivated actinobacillus pleuropneumoniae vaccine (vet.) - suspension for injection (im) - each dose (2 ml) contains: actinobacillus pleuropneumoniae antigen concentrate...................600 mg antigen concentrate contains: outer membrane protein (omp) antigen (appl-l-452 strain)..............50 units apxl antigen (app hv169 strain) ..................50 units apxii antigen (app hv143 strain) ..................50 units apxii + apxiii antigen (app 2 strain) .................50 units antigens incorporated in aqueous adjuvant contains: dl-a-tocopherol acetate................150 mg polysorbate 80..................60 mg simethicone ...............100 mcg sodium chloride ..................11 mg formalin ................1.08 mg water ......2 ml 150 mg 60 mg 100 mcg 11 mg ... 1.08 mg ........ 2 ml

PORCILIS APPVAC PLEUROPNEUMONIA VACCINE FOR PIGS Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

porcilis appvac pleuropneumonia vaccine for pigs

intervet australia pty limited - actinobacillus pleuropneumoniae serovar 15; actinobacillus pleuropneumoniae serovar 1; actinobacillus pleuropneumonie serovar 7; haemolysin toxoid; formaldehyde; thiomersal - misc. vaccines or anti sera - actinobacillus pleuropneumoniae serovar 15 vaccine-microbial active 0.0 units/ml; actinobacillus pleuropneumoniae serovar 1 vaccine-microbial active 0.0 units/ml; actinobacillus pleuropneumonie serovar 7 vaccine-microbial active 0.0 units/ml; haemolysin toxoid vaccine-toxoid active 18.0 hu/ml; formaldehyde aldehyde other 0.05 mg/ml; thiomersal mercury other 0.1 mg/ml - immunotherapy - pigs | boar | gilt | piglet | sow | swine - actinobacillus pleuropneumoniae (haemoph

Ingelvac H Formulation: Each 2 mL (dose) contains: Actinobacillus pleuropneumoniae, Serovar 1,2,3,4,5 and 7......................> 107 CFU (before inactivation) CFU - Colony Forming Unit Suspension for Injection (IM) Philippines - English - FDA (Food And Drug Administration)

ingelvac h formulation: each 2 ml (dose) contains: actinobacillus pleuropneumoniae, serovar 1,2,3,4,5 and 7......................> 107 cfu (before inactivation) cfu - colony forming unit suspension for injection (im)

boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - inactivated actinobacillus pleuropneumoniae vaccine (vet.) - suspension for injection (im) - formulation: each 2 ml (dose) contains: actinobacillus pleuropneumoniae, serovar 1,2,3,4,5 and 7......................> 107 cfu (before inactivation) cfu - colony forming unit

Suivac APP Formulation: Each 2 mL (dose) contains: Actinobacillus pleuropneumoniae, Serotype 2 and 9 ..................................>1U U-number of units in reference serum Emulsion for Injection (IM/ID) Philippines - English - FDA (Food And Drug Administration)

suivac app formulation: each 2 ml (dose) contains: actinobacillus pleuropneumoniae, serotype 2 and 9 ..................................>1u u-number of units in reference serum emulsion for injection (im/id)

broadchem philippines biopharma corporation - inactivated actinobacillus pleuropneumoniae vaccine (vet.) - emulsion for injection (im/id) - formulation: each 2 ml (dose) contains: actinobacillus pleuropneumoniae, serotype 2 and 9 ..................................>1u u-number of units in reference serum

Suigen APP+PM Formulation: Each 2 mL (dose) contains: Actinobacillus pleuropneumoniae Type 1, 2 and 5 ....... >10^ 9.2 CFU before inactivation Pasteurella multocida, Type D (Pm-18 Strain) ......... >10^ 9.2 CFU before inactivation CFU - Colony Forming Unit Suspension for Injection (IM) Philippines - English - FDA (Food And Drug Administration)

suigen app+pm formulation: each 2 ml (dose) contains: actinobacillus pleuropneumoniae type 1, 2 and 5 ....... >10^ 9.2 cfu before inactivation pasteurella multocida, type d (pm-18 strain) ......... >10^ 9.2 cfu before inactivation cfu - colony forming unit suspension for injection (im)

virbac phillippines inc. - inactivated actinobacillus pleuropneumoniae , pasteurella multocida vaccine (vet.) - suspension for injection (im) - formulation: each 2 ml (dose) contains: actinobacillus pleuropneumoniae type 1, 2 and 5 ....... >10^ 9.2 cfu before inactivation pasteurella multocida, type d (pm-18 strain) ......... >10^ 9.2 cfu before inactivation cfu - colony forming unit

Res-Vac Formulation: Each 2 mL (dose) contains: Bordetella bronchiseptica (Bb1 Strain) ... 21.5 x 1010 CFU Bordetella bronchiseptica Toxoid ....... .............. 500 ug Pasteurella multocida, Type A and D..... ....... 21.5 x 1010 CFU Pasteurella multocida Type D Toxoid ............... 500 ug Actinobacillus pleuropneumoniae, Type 2 and 5 ................. ..... 21 x 1010 CFU Actinobacillus pleuropneumoniae, Type 2 and 5 Toxoid .......... ................ 100 ug Glaesserella parasuis, Type 4 and 5 ........... ........ 24 x 10°CFU Mesomycoplasma hyopneumoniae (J101 Strain) .............. ........ 22 x 108 CFU CFU - Colony Forming Unit Suspension for Injection (IM) Philippines - English - FDA (Food And Drug Administration)

res-vac formulation: each 2 ml (dose) contains: bordetella bronchiseptica (bb1 strain) ... 21.5 x 1010 cfu bordetella bronchiseptica toxoid ....... .............. 500 ug pasteurella multocida, type a and d..... ....... 21.5 x 1010 cfu pasteurella multocida type d toxoid ............... 500 ug actinobacillus pleuropneumoniae, type 2 and 5 ................. ..... 21 x 1010 cfu actinobacillus pleuropneumoniae, type 2 and 5 toxoid .......... ................ 100 ug glaesserella parasuis, type 4 and 5 ........... ........ 24 x 10°cfu mesomycoplasma hyopneumoniae (j101 strain) .............. ........ 22 x 108 cfu cfu - colony forming unit suspension for injection (im)

nobel vet, inc.; distributor: nobel vet, inc. - inactivated bordetella bronchiseptica , pasteurella multocida , actinobacillus pleuropneumoniae , glaesserella parasuis , mesomycoplasma hyopneumoniae vaccine (vet.) - suspension for injection (im) - formulation: each 2 ml (dose) contains: bordetella bronchiseptica (bb1 strain) ... 21.5 x 1010 cfu bordetella bronchiseptica toxoid ....... .............. 500 ug pasteurella multocida, type a and d..... ....... 21.5 x 1010 cfu pasteurella multocida type d toxoid ............... 500 ug actinobacillus pleuropneumoniae, type 2 and 5 ................. ..... 21 x 1010 cfu actinobacillus pleuropneumoniae, type 2 and 5 toxoid .......... ................ 100 ug glaesserella parasuis, type 4 and 5 ........... ........ 24 x 10°cfu mesomycoplasma hyopneumoniae (j101 strain) .............. ........ 22 x 108 cfu cfu - colony forming unit

PLEURAVAC - PLEUROPNEUMONIA VACCINE FOR PIGS Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

pleuravac - pleuropneumonia vaccine for pigs

intervet australia pty limited - isotonic medium not less than 18 hu/ml haemolysin toxoid; actinobacillus pleuropneumoniae serovar 15; actinobacillus pleuropneumoniae serovar 1; formaldehyde; thiomersal - parenteral liquid/solution/suspension - isotonic medium not less than 18 hu/ml haemolysin toxoid ungrouped active 0.0 p; actinobacillus pleuropneumoniae serovar 15 vaccine-microbial active 0.0 p; actinobacillus pleuropneumoniae serovar 1 vaccine-microbial active 0.0 p; formaldehyde aldehyde other 0.05 mg/ml; thiomersal mercury other 0.1 mg/ml - immunotherapy - pigs | boar | gilt | piglet | sow | swine - actinobacillus pleuropneumoniae (haemoph | vaccine | equine rotavirus

SuiShot APM-7 Each 1 mL (dose) contains: Pasteurella multocida, Type A (NSPA Strain) .......... 2,000,000,000 CFU Type D (PDNT Strain) ........ ... 2,000,000,000 CFU Actinobacillus pleuropneumoniae, Serotype 2 (NSA252 Strain)........... 1,000,000,000 CFU Serotype 5 (NSAS Strain) .............. 1,000,000,000 CFU Serotype 2 Toxin (NSA252 Strain) ... 10 ug Serotype 5 Toxin (NSA5 Strain) ....... 10 ug CFU -Colony Forming Unit Suspension for Injection (IM) Philippines - English - FDA (Food And Drug Administration)

suishot apm-7 each 1 ml (dose) contains: pasteurella multocida, type a (nspa strain) .......... 2,000,000,000 cfu type d (pdnt strain) ........ ... 2,000,000,000 cfu actinobacillus pleuropneumoniae, serotype 2 (nsa252 strain)........... 1,000,000,000 cfu serotype 5 (nsas strain) .............. 1,000,000,000 cfu serotype 2 toxin (nsa252 strain) ... 10 ug serotype 5 toxin (nsa5 strain) ....... 10 ug cfu -colony forming unit suspension for injection (im)

agrimate, inc.; distributor: agrimate, inc. - inactivated pasteurella multocida , actinobacillus pleuropneumoniae toxoid vaccine (vet.) - suspension for injection (im) - each 1 ml (dose) contains: pasteurella multocida, type a (nspa strain) .......... 2,000,000,000 cfu type d (pdnt strain) ........ ... 2,000,000,000 cfu actinobacillus pleuropneumoniae, serotype 2 (nsa252 strain)........... 1,000,000,000 cfu serotype 5 (nsas strain) .............. 1,000,000,000 cfu serotype 2 toxin (nsa252 strain) ... 10 ug serotype 5 toxin (nsa5 strain) ....... 10 ug cfu -colony forming unit